Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8334 Linsitinib3 CitationSummary: IGF1R/IR inhibitor,potent and novel -
A8350 AZD4547Target: FGFRSummary: FGFR inhibitor -
A8345 PF-562271 HClTarget: FAK|Pyk2Summary: FAK/Pyk2 inhibitor -
A8347 Pazopanib HydrochlorideSummary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor -
A8357 AG-1478Target: EGFRSummary: EGFR inhibitor,potent and selective -
A8361 AMG-458Summary: Potent c-Met inhibitor -
A8365 Varlitinib (ARRY334543)Summary: ErbB inhibitor -
A8366 ARRY-380Target: HER2Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor -
A8367 AST-1306Summary: EGFR/HER2 inhibitor -
A8370 Axitinib (AG 013736)5 CitationTarget: VEGFR|PDGFR|c-KitSummary: VEGFR1/ c-Kit inhibitor

